World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
67
Citations
36544
World Ranking
2478
National Ranking
16

Research.com Recognitions

  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Batsheva Kerem is affiliated with the Hebrew University of Jerusalem in Israel. Their research primarily centers on medical sciences, with a specific focus on pulmonary and respiratory medicine, molecular biology, and genetics. The scientist has contributed extensively to the study of cystic fibrosis and related genetic disorders.

Their recent research publications include:

  • 3D genome organization contributes to genome instability at fragile sites, 2020, Nature Communications
  • New approaches to genetic therapies for cystic fibrosis, 2020, Journal of Cystic Fibrosis
  • Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation, 2023, Journal of Cystic Fibrosis
  • Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation, 2021, Journal of Cystic Fibrosis
  • Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation, 2021, Journal of Cystic Fibrosis

Batsheva Kerem frequently publishes in the following venues:

  • Journal of Cystic Fibrosis
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Cell Reports
  • Nucleic Acid Therapeutics

Frequent coauthors collaborating with Batsheva Kerem include:

  • Yifat S. Oren
  • E. Ozeri-Galai
  • Eitan Kerem
  • Gili Hart
  • Michael Wilschanski

The main fields of study encompass:

  • Medicine

Within this broad field, subfields of focus include:

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Genetics
  • Oncology
  • Electrical and Electronic Engineering

Their main topics of research cover:

  • Cystic Fibrosis Research Advances
  • Neonatal Respiratory Health Research
  • DNA Repair Mechanisms
  • Advanced biosensing and bioanalysis techniques
  • Genetics and Neurodevelopmental Disorders
  • Tracheal and airway disorders
  • Energy Harvesting in Wireless Networks

Batsheva Kerem has been recognized as a member of the European Molecular Biology Organization (EMBO).

Best Publications

  • Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

    John R. Riordan;Johanna M. Rommens;Bat Sheva Kerem;N. O.A. Alon

  • Identification of the cystic fibrosis gene: genetic analysis.

    Bat Sheva Kerem;Johanna M. Rommens;Janet A. Buchanan;Danuta Markiewicz

  • Identification of the cystic fibrosis gene: Chromosome walking and jumping

    Johanna M. Rommens;Michael C. Iannuzzi;Bat Sheva Kerem;Mitchell L. Drumm

  • The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

    Eitan Kerem;Mary Corey;Bat-sheva Kerem;Johanna Rommens

  • Nucleotide deficiency promotes genomic instability in early stages of cancer development.

    Assaf C. Bester;Maayan Roniger;Yifat S. Oren;Michael M. Im

  • Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

    C. Castellani;H. Cuppens;M. Macek;J. J. Cassiman

  • Correlation between genotype and phenotype in patients with cystic fibrosis.

    Augarten A;Kerem Bs;Kerem E;Gazit E

  • Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

    Julian Zielenski;Richard Rozmahel;Dominique Bozon;Bat sheva Kerem

  • Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.

    Michael Wilschanski;Yaacov Yahav;Yasmin Yaacov;Hannah Blau

  • Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene.

    B S Kerem;J Zielenski;D Markiewicz;D Bozon

  • Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

    Eitan Kerem;Samit Hirawat;Shoshana Armoni;Yasmin Yaakov

  • Recommendations for the classification of diseases as CFTR-related disorders

    Cristina Bombieri;M Claustres;K De Boeck;N Derichs

  • Developmental Dyscalculia Is a Familial Learning Disability

    Ruth S. Shalev;Orly Manor;Batsheva Kerem;Mady Ayali

  • A role for common fragile site induction in amplification of human oncogenes.

    Asaf Hellman;Eitan Zlotorynski;Stephen W Scherer;Joseph Cheung

  • Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin

    Liat Linde;Stephanie Boelz;Malka Nissim-Rafinia;Yifat S. Oren

  • Molecular basis for expression of common and rare fragile sites

    Eitan Zlotorynski;Ayelet Rahat;Jennifer Skaug;Neta Ben-Porat

  • Splicing regulation as a potential genetic modifier

    Malka Nissim-Rafinia;Batsheva Kerem

  • The presence of extra chromosomes leads to genomic instability.

    Verena Passerini;Efrat Ozeri-Galai;Mirjam S. de Pagter;Neysan Donnelly

  • A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations.

    Michael Wilschanski;Chagit Famini;Hannah Blau;Joseph Rivlin

  • Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis.

    Wanda K. Lemna;Gerald L. Feldman;Bat-sheva Kerem;Susan D. Fernbach

Frequent Co-Authors

Johanna M. Rommens
Johanna M. Rommens University of Toronto
Lap-Chee Tsui
Lap-Chee Tsui University of Toronto
John R. Riordan
John R. Riordan University of North Carolina at Chapel Hill
Francis S. Collins
Francis S. Collins National Institutes of Health
Julian Zielenski
Julian Zielenski University of Toronto
Stephen W. Scherer
Stephen W. Scherer University of Toronto
Michal Schwartz
Michal Schwartz Weizmann Institute of Science
Pier Franco Pignatti
Pier Franco Pignatti University of Verona
Milan Macek
Milan Macek Charles University
Harry Cuppens
Harry Cuppens KU Leuven

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Genetics opens doors to diverse career options in healthcare, research, and education. Many students combine their genetics background with professional qualifications in nursing or advanced practice to increase job opportunities and earning potential.

For individuals interested in integrating genetics with clinical practice, several online pathways exist. Aspiring nurse practitioners can explore affordable fnp programs that offer flexible learning and specializations, which may include genetics-focused care. Some students begin their journey through an online nursing school to obtain foundational licensure and nursing skills.

For those looking to advance their careers further, the cheapest dnp programs can lead to leadership roles in genetics research, clinical practice, or academia. Alternatively, nurses with an associate degree may consider the best online rn to bsn programs to strengthen their credentials, potentially focusing on genetics within their studies.

Choosing an online program can provide flexibility, affordability, and access to specialized training—important factors for those wishing to align a genetics background with in-demand healthcare roles.

Best Scientists Citing Batsheva Kerem

Trending Scientists

Recently Published Articles